Synexus takes just ten months to carry out 52,000 DEXA scans

It took clinical trial experts Synexus, just ten months to carry out 52,000 DEXA scans and randomise over 2,700 patients across twelve of their UK, European and African dedicated research centres.

“We can already demonstrate our capacity to handle tens of thousands of screenings in a very short space of time, now that we have expanded our operations, this is only going to improve.”

Commenting on the company’s success recruiting patients for this Phase III osteoporosis trial for a top five pharma company chief executive Michael Fort said: “Once again our model has been shown to deliver the right numbers of patients at the right time even when it involves such a large scale logistical exercise. This was a complex late stage trial requiring mass screening of potential patients for randomization into the study. The company routinely screened over 1,000 patients a week for almost 12 months. Ultimately we were by far the largest clinical trials recruiter for this study, responsible for bringing in 23% of the patients in the global programme from less than 3% of the sites. All of our centres are equipped with state-of-the-art facilities including DEXA scanners. Our dedicated research centres, with full-time investigators are the way forward, helping us to recruit more quickly, and, in a big study, reducing set up and monitoring costs by millions of dollars.”